Sphera Funds Management as of Sept. 30, 2020
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 92 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 7.9 | $80M | 915k | 87.59 | |
| Merck & Co (MRK) | 7.2 | $73M | 884k | 82.95 | |
| Sarepta Therapeutics (SRPT) | 6.5 | $66M | 472k | 140.43 | |
| Invesco Qqq Tr Put Put Option (QQQ) | 5.7 | $58M | 210k | 277.84 | |
| Johnson & Johnson (JNJ) | 5.6 | $57M | 380k | 148.88 | |
| Sanofi Sponsored Adr (SNY) | 5.5 | $56M | 1.1M | 50.17 | |
| Eli Lilly & Co. (LLY) | 5.2 | $53M | 356k | 148.02 | |
| Astrazeneca Sponsored Adr (AZN) | 4.4 | $45M | 820k | 54.80 | |
| Amgen (AMGN) | 2.7 | $28M | 110k | 254.16 | |
| Novartis Sponsored Adr (NVS) | 2.4 | $25M | 285k | 86.96 | |
| Deciphera Pharmaceuticals (DCPH) | 1.7 | $18M | 344k | 51.30 | |
| Amicus Therapeutics (FOLD) | 1.7 | $18M | 1.2M | 14.12 | |
| Y Mabs Therapeutics (YMAB) | 1.5 | $15M | 397k | 38.39 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.4 | $14M | 1.6M | 9.01 | |
| Nice Sponsored Adr (NICE) | 1.4 | $14M | 63k | 227.03 | |
| Generac Holdings (GNRC) | 1.3 | $13M | 67k | 193.64 | |
| Ishares Tr Put Put Option (IWP) | 1.2 | $13M | 74k | 172.87 | |
| Amazon (AMZN) | 1.2 | $12M | 3.8k | 3148.69 | |
| Bioxcel Therapeutics (BTAI) | 1.1 | $12M | 269k | 43.36 | |
| Myokardia | 1.1 | $11M | 81k | 136.33 | |
| Kura Oncology (KURA) | 1.1 | $11M | 360k | 30.64 | |
| Microsoft Corporation (MSFT) | 1.1 | $11M | 51k | 210.32 | |
| Allot SHS (ALLT) | 0.9 | $9.5M | 1.0M | 9.10 | |
| Kornit Digital SHS (KRNT) | 0.9 | $9.3M | 143k | 64.87 | |
| Trillium Therapeutics Com New | 0.9 | $9.2M | 645k | 14.21 | |
| Facebook Cl A (META) | 0.9 | $9.2M | 35k | 261.91 | |
| I Mab Sponsored Ads (IMAB) | 0.8 | $8.6M | 182k | 47.03 | |
| Immatics SHS (IMTX) | 0.8 | $8.5M | 800k | 10.61 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $8.3M | 253k | 32.92 | |
| Jfrog Ord Shs (FROG) | 0.8 | $8.1M | 95k | 84.65 | |
| Fiverr Intl Ord Shs (FVRR) | 0.8 | $8.0M | 57k | 138.99 | |
| Krystal Biotech (KRYS) | 0.8 | $7.9M | 185k | 43.05 | |
| Wave Life Sciences SHS (WVE) | 0.8 | $7.9M | 931k | 8.49 | |
| Repare Therapeutics Ord (RPTX) | 0.7 | $7.5M | 245k | 30.77 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $7.5M | 510k | 14.76 | |
| Fate Therapeutics (FATE) | 0.7 | $7.5M | 188k | 39.97 | |
| Fiserv (FI) | 0.7 | $7.2M | 70k | 103.05 | |
| Burlington Stores (BURL) | 0.7 | $7.2M | 35k | 206.09 | |
| Varonis Sys (VRNS) | 0.7 | $7.0M | 60k | 115.42 | |
| Domino's Pizza (DPZ) | 0.7 | $6.9M | 16k | 425.25 | |
| Alx Oncology Hldgs (ALXO) | 0.7 | $6.9M | 182k | 37.74 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.6 | $6.4M | 195k | 32.69 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $6.2M | 1.0M | 6.24 | |
| Iteos Therapeutics (ITOS) | 0.6 | $6.2M | 250k | 24.67 | |
| Immunovant (IMVT) | 0.6 | $6.0M | 170k | 35.19 | |
| Albireo Pharma | 0.6 | $5.8M | 174k | 33.37 | |
| Reata Pharmaceuticals Cl A | 0.6 | $5.8M | 59k | 97.41 | |
| Arena Pharmaceuticals Com New | 0.6 | $5.6M | 75k | 74.79 | |
| Arya Sciences Acquistion Unit 06/09/2027 | 0.5 | $5.5M | 499k | 11.00 | |
| Celldex Therapeutics Com New (CLDX) | 0.5 | $5.5M | 370k | 14.83 | |
| Mirati Therapeutics | 0.5 | $5.5M | 33k | 166.06 | |
| Axovant Gene The | 0.5 | $5.3M | 1.2M | 4.62 | |
| Rocket Pharmaceuticals (RCKT) | 0.5 | $5.2M | 228k | 22.86 | |
| Larimar Therapeutics (LRMR) | 0.5 | $5.2M | 342k | 15.17 | |
| Kymera Therapeutics (KYMR) | 0.5 | $5.2M | 160k | 32.31 | |
| Inozyme Pharma (INZY) | 0.5 | $5.2M | 196k | 26.29 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.5 | $5.0M | 33k | 154.33 | |
| Uniqure Nv SHS (QURE) | 0.5 | $4.6M | 126k | 36.83 | |
| Arya Sciences Acquisition Com Cl A | 0.4 | $4.3M | 400k | 10.72 | |
| Galera Therapeutics (GRTX) | 0.4 | $4.2M | 469k | 9.04 | |
| Avrobio Ord (AVRO) | 0.4 | $4.2M | 326k | 13.02 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.4 | $4.0M | 260k | 15.32 | |
| Zymeworks | 0.4 | $3.7M | 80k | 46.58 | |
| Dicerna Pharmaceuticals | 0.4 | $3.6M | 200k | 17.99 | |
| Passage Bio (PASG) | 0.3 | $3.5M | 266k | 13.11 | |
| Perrigo SHS (PRGO) | 0.3 | $3.3M | 72k | 45.91 | |
| Altimmune Com New (ALT) | 0.3 | $3.2M | 243k | 13.20 | |
| Arvinas Ord (ARVN) | 0.3 | $3.2M | 135k | 23.61 | |
| Concert Pharmaceuticals I equity | 0.3 | $3.0M | 310k | 9.82 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $3.0M | 240k | 12.59 | |
| Argenx Se Sponsored Adr (ARGX) | 0.3 | $2.7M | 10k | 262.54 | |
| Adma Biologics (ADMA) | 0.3 | $2.6M | 1.1M | 2.39 | |
| Athira Pharma (ATHA) | 0.2 | $2.1M | 112k | 18.46 | |
| Orgenesis Com New (ORGS) | 0.2 | $2.0M | 399k | 5.04 | |
| Alpine Immune Sciences (ALPN) | 0.2 | $1.7M | 198k | 8.79 | |
| Essa Pharma Com New (EPIX) | 0.2 | $1.7M | 250k | 6.90 | |
| Leap Therapeutics | 0.2 | $1.6M | 800k | 1.98 | |
| 89bio (ETNB) | 0.1 | $1.5M | 59k | 25.65 | |
| Dyne Therapeutics (DYN) | 0.1 | $1.4M | 70k | 20.19 | |
| Exicure | 0.1 | $1.3M | 738k | 1.75 | |
| Neubase Therapeutics Ord | 0.1 | $1.1M | 150k | 7.59 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $1.1M | 100k | 11.00 | |
| Pandion Therapeutics | 0.1 | $1.1M | 95k | 11.46 | |
| Solaredge Technologies (SEDG) | 0.1 | $957k | 4.0k | 238.24 | |
| Nurix Therapeutics (NRIX) | 0.1 | $785k | 23k | 34.92 | |
| Nice Sys Note 1.250% 1/1 | 0.1 | $681k | 250k | 2.72 | |
| Cardiff Oncology (CRDF) | 0.1 | $568k | 40k | 14.20 | |
| Immatics *w Exp 07/01/202 (IMTXW) | 0.0 | $350k | 100k | 3.50 | |
| Therapeutics Acquisition Cor Com Cl A | 0.0 | $288k | 20k | 14.40 | |
| Corbus Pharmaceuticals Hldgs Call Call Option | 0.0 | $141k | 79k | 1.80 | |
| Cellectar Biosciences Com Par | 0.0 | $109k | 88k | 1.25 | |
| Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $17k | 130k | 0.13 |
